Concepedia
Statistics
Publications
33
Citations
1.6K
H-Index
24
Active since
2012
Affiliations
University of Freiburg(Current)
University Medical Center Freiburg
Kantonsspital St. Gallen
University Hospital Regensburg
The University of Sydney
Bjoern Moosmann is an author at University of Freiburg specializing in pharmacology, pharmacy, and cannabinoid pharmacology.
Publications per year
2012–2022
Characteristics of the designer drug and synthetic cannabinoid receptor agonist AM‐2201 regarding its chemistry and metabolism
Melanie Hutter, Bjoern Moosmann, Stefan Kneisel et al. · Journal of Mass Spectrometry · 2013 · 102 citations
Medicine, Pharmacology, Toxicology +8
Detection of the recently emerged synthetic cannabinoid 5F–MDMB‐PICA in ‘legal high’ products and human urine samples
Lukas Mogler, Florian Franz, Daniel Rentsch et al. · Drug Testing and Analysis · 2017 · 98 citations
Pharmacy, Medicinal Chemistry, Pharmacology +17
Detection and identification of the designer benzodiazepine flubromazepam and preliminary data on its metabolism and pharmacokinetics
Bjoern Moosmann, Laura M. Huppertz, Melanie Hutter et al. · Journal of Mass Spectrometry · 2013 · 93 citations
Pharmacy, Pharmacokinetics, Pharmacology +17
Characterization of the designer benzodiazepine diclazepam and preliminary data on its metabolism and pharmacokinetics
Bjoern Moosmann, Philippe Bisel, Volker Auwärter · Drug Testing and Analysis · 2014 · 87 citations
Designer Benzodiazepines: Another Class of New Psychoactive Substances
Bjoern Moosmann, Volker Auwärter · Handbook of experimental pharmacology · 2018 · 87 citations
Medicine, Pharmacology, Pharmacotherapy +7
1–5 of 33